Clinical trial suggests olaparib effective in mutant IDH1/2 brain tumours

In a new study, Yale researchers identified a novel genetic defect that prevents brain tumour cells from repairing damaged DNA. They found that the defect is highly sensitive to an existing FDA-approved drug used to treat ovarian cancer -- a discovery...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2kWREbq
via IFTTT